UY36922A - Inhibidores de asgr - Google Patents

Inhibidores de asgr

Info

Publication number
UY36922A
UY36922A UY0001036922A UY36922A UY36922A UY 36922 A UY36922 A UY 36922A UY 0001036922 A UY0001036922 A UY 0001036922A UY 36922 A UY36922 A UY 36922A UY 36922 A UY36922 A UY 36922A
Authority
UY
Uruguay
Prior art keywords
asgr
methods
binding proteins
inhibitors
administering
Prior art date
Application number
UY0001036922A
Other languages
English (en)
Inventor
Paul Nioi
Peter Coward
Christopher Murawsky
Derek E Piper
Fernando Garces
Jun Zhang
Yang Li
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of UY36922A publication Critical patent/UY36922A/es

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describen proteínas de unión al antígeno que interactúan con ASGR, ASGR-1 y/o ASGR-2, así como métodos para producir y utilizar dichas proteínas de unión al antígeno. Métodos para tratar y prevenir la enfermedad cardiovascular mediante la administración de una cantidad farmacéuticamente eficaz de proteínas de unión al antígeno de ASGR, ASGR-1 y/o ASGR-2. Se describen métodos para tratar y prevenir la enfermedad cardiovascular mediante la administración de una cantidad farmacéuticamente eficaz de composiciones de ARN interferente que reducen la expresión de ASGR, ASGR-1 y/o ASGR-2.
UY0001036922A 2015-09-29 2016-09-28 Inhibidores de asgr UY36922A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562234546P 2015-09-29 2015-09-29
US201562259533P 2015-11-24 2015-11-24
US201662319740P 2016-04-07 2016-04-07

Publications (1)

Publication Number Publication Date
UY36922A true UY36922A (es) 2017-03-31

Family

ID=58689632

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001036922A UY36922A (es) 2015-09-29 2016-09-28 Inhibidores de asgr

Country Status (2)

Country Link
TW (1) TW201726726A (es)
UY (1) UY36922A (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116948030A (zh) * 2022-04-25 2023-10-27 武汉大学 抗asgr1单克隆抗体及其应用

Also Published As

Publication number Publication date
TW201726726A (zh) 2017-08-01

Similar Documents

Publication Publication Date Title
CO2018000104A2 (es) Moléculas de anticuerpo que se unen a cd22
EA201890285A1 (ru) Антитела против pd-1, активируемые антитела против pd-1 и способы их применения
CL2018000429A1 (es) Moduladores de la expresión de kras
EA201990293A1 (ru) Мультиспецифичные антитела против cd40 и cd137
EA201891983A1 (ru) Комбинированная терапия антителами к cd73
CU24498B1 (es) Anticuerpos de factor xi
MX2022011002A (es) Anticuerpos de grupo de diferenciacion 3 (cd3) humanizados o quimericos.
CO2018000211A2 (es) Moléculas de anticuerpo que se unen a cd45
EA201792413A1 (ru) Антитела против cd71, активируемые антитела против cd71 и способы их применения
EA201890630A1 (ru) Антитела против pd-1 и способы их применения
EP4249515A3 (en) Humanized or chimeric cd3 antibodies
MX2018008934A (es) Anticuerpos anti-ror1, anticuerpos biespecíficos ror1 x cd3 y métodos para su uso.
EA201891339A1 (ru) Водный фармацевтический препарат, который содержит антитело к pd-l1 авелумаб
MX2016012124A (es) Anticuerpos contra glicopeptidos inmunogenicos, composicion que los comprende y usos de estos.
CO2018000410A2 (es) Moléculas de anticuerpo que se unen a cd79
WO2018151821A8 (en) ANTI-ALPHA-SYNUCLEIN ANTIBODIES AND USES THEREOF
WO2016044189A8 (en) Methods of treating cancer using pd-1 axis binding antagonists and il-17 binding antagonists
PH12014501122A1 (en) Methods of treatment using an antibody against interferon gamma
EA201690881A1 (ru) Соединения-ингибиторы аутотаксина
EA201692204A1 (ru) Композиции и способы модулирования экспрессии фактора комплемента b
MX2018015272A (es) Anticuerpos anti-cd98 y conjugados de anticuerpo y farmaco.
BR112015030356A2 (pt) métodos de tratamento de uma taupatia
MX2018015274A (es) Anticuerpos anti-cd98 y conjugados de anticuerpo y farmaco.
EA201890747A1 (ru) Способы лечения воспалительных заболеваний
EA201890572A1 (ru) Биофармацевтические композиции

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20221129